ADC Therapeutics SA
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
72.66 |
77.69 |
83.39 |
143.69 |
274.58 |
387.61 |
Przychód Δ r/r |
0.00% |
6.92% |
7.34% |
72.30% |
91.10% |
41.17% |
Przychód (min) |
72.36 |
75.73 |
68.60 |
132.82 |
253.81 |
358.29 |
Przychód (max) |
72.98 |
80.10 |
116.60 |
166.08 |
317.37 |
448.03 |
EBITDA (średnia) |
-36.55 |
-39.07 |
-41.94 |
-72.27 |
-138.10 |
-194.95 |
EBIT (średnia) |
-36.71 |
-39.25 |
-42.13 |
-72.59 |
-138.72 |
-195.83 |
EBIT % |
-50.52% |
-50.52% |
-50.52% |
-50.52% |
-50.52% |
-50.52% |
Zysk netto (średni) |
-149.84 |
-150.40 |
-159.79 |
-120.15 |
-16.76 |
42.02 |
Zysk netto % |
-206.21% |
-193.59% |
-191.60% |
-83.62% |
-6.10% |
10.84% |
EPS (średnia) |
-1.69 |
-1.55 |
-1.32 |
-0.93 |
-0.17 |
0.43 |
Liczba analityków (Przychody) |
5 |
4 |
5 |
5 |
1 |
2 |
Liczba analityków (EPS) |
6 |
6 |
5 |
5 |
2 |
1 |
symbol |
ADCT |
ADCT |
ADCT |
ADCT |
ADCT |
ADCT |